ceptance to publication has decreased. 2 The posting of preprints allows findings to be distributed immediately for discussion by the research community, while simultaneously enabling investigators to establish ownership and priority of new ideas.
The use of preprint servers is not without cost, however. In particular, significant concerns have been raised in the life sciences when reporting potentially impacts the evaluation, management, and treatment of humans. This view argues that studies in the life sciences are inherently different from those in disciplines like mathematics and physics. It is possible that most casual visitors to a preprint server are unlikely to take the time, or have the requisite expertise, to critically evaluate a report that could nonetheless affect clinical practice. The extent to which postings are prepared by authors who misinterpret (or overinterpret) their findings heightens this risk. And despite the hope that posting a preprint will spur discussion and debate about a topic, most studies are viewed rarely (if at all).
Some may rightfully point out that these issues are also true for abstracts or preliminary communications at scientific meetings (and even many published articles, for that matter, given that peer review is far from perfect). Yet over time researchers have developed an understanding that abstracts require further validation before being incorporated into clinical practice. The same culture does not exist around preprints at this time. This concern may explain why even in the life sciences, preprints have been adopted much more by basic scientists than by clinical researchers. For example, on bioRxiv right now, there are thousands of postings under topics such as genomics and bioinformatics but only a handful related to clinical trials.
Practical concerns about posting a preprint also exist. Some journals consider preprints as violating the widely adopted Ingelfinger rule, first established by the editors of The New England Journal of Medicine decades ago. 3 This rule requires that articles under consideration by a journal are not previously published or under review at another journal. Its overall purpose is to ensure an article's novel contribution to the literature. The Ingelfinger rule has maintained remarkable durability over the years, prohibiting submission to many journals of manuscripts already posted online as preprints.
However, some journals have begun to move in a new direction and no longer consider preprints as violating the Ingelfinger rule. Even for these journals, some authors have run into tough situations. A prominent example from 2012 suggested that a physics report in Nature was rejected after an initially favorable reviseand-resubmit decision because of the attention drawn to the manuscript as a preprint. 4 This implies that journals may be less interested in an author's work if it has already been made available to the public, especially if it is widely discussed. Pages in medical journals are a limited resource, and editors like to use this resource on science they believe is novel. This is an especially important concern for junior investigators who rely on publications in peer-reviewed journals for promotion and academic credit. A related concern by investigators is the possibility of being scooped by others without appropriate attribution when their work is available only as a preprint.
Notwithstanding these issues, a few preprint servers have been established in the life sciences in recent years and have generated substantial interest. The most prominent of these is hosted by the website bioRxiv, which was established in 2013. Influential journals such as Nature, Science, The Lancet, and The BMJ now explicitly state that they will no longer consider manuscripts posted on preprint servers as prior publications, bypassing the Ingelfinger rule. Simultaneously, funders like the National Institutes of Health and the Wellcome Trust have begun to allow preprints to be referenced in grant applications. The American Heart Association has also updated its policy to allow applicants "to cite interim research products, such as preprints, as part of their grant applications." The American Heart Association defines preprints in this context as "a complete and public draft of a scientific document" that is "written in the style of a peer-reviewed journal article." Finally, a growing number of prominent scientists have come out in favor of preprints as a means of accelerating scientific reporting. 5 The recent Zika virus outbreak is a telling example of how the research community rallied around the need to push forward scientific reporting during a public health emergency, and the potential future of preprints. Given urgent concerns around that crisis, many journals, including those historically reluctant to consider reports previously disseminated as preprints, agreed to suspend their prior policies. The overall value of getting information quickly into the open for debate and immediate public vetting was believed to outweigh concerns of posting unreviewed clinical data. But if altering this balance between research reliability and timeliness was important for the Zika virus crisis, why should it be less so for other topics or at other times? On the flip side, it is true that much of scientific reporting lacks a degree of urgency comparable to that occurring with the Zika virus outbreak that would require journals to prioritize speed over research reliability.
At Circulation, Circulation: Cardiovascular Quality and Outcomes, and the other journals in the American Heart Association portfolio, these trends have encouraged us to revisit our policies regarding preprints. We believe there undoubtedly will be an increase in authors' interest in posting manuscripts to preprint servers before submitting their work to our journals for formal publication. Our policy to date has not explic-itly addressed this issue. Thus, we engaged in recent discussions regarding our policy and this burgeoning trend. In these conversations, many editors expressed both enthusiasm and concerns related to the preprint movement, largely reflecting the reasons previously mentioned in this article.
Based on these deliberations, organizational leadership established a policy that American Heart Association journals will consider manuscripts that have been previously posted online with authors specifically asked at the time of submission if their work was deposited in a preprint server. The full policy is available online at http://www.ahajournals.org/content/priorpublication-policy. Authors should be aware, however, that there could be implications of posting to preprint servers. For example, we reserve the right to consider how the posting of a preprint might affect decisions around priority, because a key goal of all the American Heart Association journals is to publish articles that are meaningful advances in science. This means that we view the policy as a tool for editors and a guidepost for authors, not an endorsement or repudiation of the preprint server process. We also will allow preprints to be cited in works (like abstracts) during an initial submission, with authors expected to update the reference once a preprint is accepted for publication at a journal. We believe this approach achieves the optimal balance between ensuring the competing demands of research reliability and timeliness while allowing us to learn how preprints will ultimately impact these trends.
As editors, we are highly committed to the joint goals of publishing science of the highest quality and accelerating its dissemination. Our evolving policy regarding scientific reports disseminated as preprints is one important step in achieving these vital goals. As always, we will benefit from your feedback.
